The Phytochemical Glaucarubinone Promotes Mitochondrial Metabolism, Reduces Body Fat, and Extends Lifespan of Caenorhabditis elegans

Abstract

Naturally occurring compounds that promote energy expenditure and delay aging in model organisms may be of significant interest, since these substances potentially provide pharmaceutical approaches to tackle obesity and promote healthy lifespan in humans. We aimed to test whether pharmaceutical concentrations of glaucarubinone, a cytotoxic and antimalarial quassinoid known from different species of the plant family Simaroubaceae, are capable of affecting metabolism and/or extending lifespan in a nematodal model organism for aging processes, the roundworm Caenorhabditis elegans. Adult C. elegans roundworms, maintained on agar plates, were fed with E. coli strain OP50 bacteria, and glaucarubinone was applied to the agar to test (i) whether it alters respiration rates and mitochondrial activity, (ii) whether it affects body fat content, and (iii) whether it may promote longevity by quantifying survival in the presence and absence of the compound. We have found that glaucarubinone induces oxygen consumption and reduces body fat content of C. elegans. Moreover and consistent with the concept of mitohormesis, glaucarubinone extends C. elegans lifespan when applied at a concentration of 1 or 10 nanomolar. Taken together, glaucarubinone is capable of reducing body fat and promoting longevity in C. elegans, tentatively suggesting that this compound may promote metabolic health and lifespan in mammals and possibly humans.

Key words

obesity - aging - lifespan - phytochemicals - mitochondria - mitohormesis

References

• 1 Friedman DB, Johnson TE. A mutation in the age-1 gene in Caenorhabditis elegans lengthens life and reduces hermaphrodite fertility.  Genetics. 1988;  118 75-86
• 2 Kenyon C, Chang J, Gensch E, Rudner A, Tabtiang R. A C. elegans mutant that lives twice as long as wild type.  Nature. 1993;  366 461-464
• 3 Tatar M, Kopelman A, Epstein D, Tu MP, Yin CM, Garofalo RS. A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function.  Science. 2001;  292 107-110
• 4 Brown-Borg HM, Borg KE, Meliska CJ, Bartke A. Dwarf mice and the ageing process.  Nature. 1996;  384 33
• 5 Holzenberger M, Dupont J, Ducos B, Leneuve P, Geloen A, Even PC, Cervera P, Le Bouc Y. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice.  Nature. 2003;  421 182-187
• 6 Blüher M, Kahn BB, Kahn CR. Extended longevity in mice lacking the insulin receptor in adipose tissue.  Science. 2003;  299 572-574
• 7 Kimura KD, Tissenbaum HA, Liu Y, Ruvkun G. daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans.  Science. 1997;  277 942-946
• 8 Weindruch R, Walford RL. The retardation of aging and disease by dietary restriction.. Springfield, Illinois: Charles C Thomas Pub Ltd; 1988
• 9 Colman RJ, Anderson RM, Johnson SC, Kastman EK, Kosmatka KJ, Beasley TM, Allison DB, Cruzen C, Simmons HA, Kemnitz JW, Weindruch R. Caloric restriction delays disease onset and mortality in rhesus monkeys.  Science. 2009;  325 201-204
• 10 Vellai T, Takacs-Vellai K, Zhang Y, Kovacs AL, Orosz L, Muller F. Genetics: influence of TOR kinase on lifespan in C. elegans.  Nature. 2003;  426 620
• 11 Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, Nadon RA. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice.  Nature. 2009;  460 392-395
• 12 Kaeberlein M. Resveratrol and rapamycin: are they anti-aging drugs?.  Bioessays. 2010;  32 96-99
• 13 Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, Scherer B, Sinclair DA. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan.  Nature. 2003;  425 191-196
• 14 Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL, Tatar M, Sinclair D. Sirtuin activators mimic caloric restriction and delay ageing in metazoans.  Nature. 2004;  430 686-689
• 15 Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA. Resveratrol improves health and survival of mice on a high-calorie diet.  Nature. 2006;  444 337-342
• 16 Pearson KJ, Baur JA, Lewis KN, Peshkin L, Price NL, Labinskyy N, Swindell WR, Kamara D, Minor RK, Perez E, Jamieson HA, Zhang Y, Dunn SR, Sharma K, Pleshko N, Woollett LA, Csiszar A, Ikeno Y, Le Couteur D, Elliott PJ, Becker KG, Navas P, Ingram DK, Wolf NS, Ungvari Z, Sinclair DA, de Cabo R. Resveratrol Delays Age-Related Deterioration and Mimics Transcriptional Aspects of Dietary Restriction without Extending Life Span.  Cell Metab. 2008;  8 157-168
• 17 Schulz TJ, Zarse K, Voigt A, Urban N, Birringer M, Ristow M. Glucose restriction extends Caenorhabditis elegans life span by inducing mitochondrial respiration and increasing oxidative stress.  Cell Metab. 2007;  6 280-293
• 18 Ghosh PC, Larrahondo JE, LeQuesne PW, Raffauf RF. Antitumor plants. IV. Constituents of Simarouba versicolor.  Lloydia. 1977;  40 364-369
• 19 Ogura M, Cordell GA, Kinghorn AD, Farnsworth NR. Potential anticancer agents vi. Constituents of Ailanthus excelsa (Simaroubaceae).  Lloydia. 1977;  40 579-584
• 20 Valeriote FA, Corbett TH, Grieco PA, Moher ED, Collins JL, Fleck TJ. Anticancer activity of glaucarubinone analogues.  Oncol Res. 1998;  10 201-208
• 21 Trager W, Polonsky J. Antimalarial activity of quassinoids against chloroquine-resistant Plasmodium falciparum in vitro.  Am J Trop Med Hyg. 1981;  30 531-537
• 22 O’Neill MJ, Bray DH, Boardman P, Wright CW, Phillipson JD, Warhurst DC, Gupta MP, Correya M, Solis P. Plants as sources of antimalarial drugs, Part 6: Activities of Simarouba amara fruits.  J Ethnopharmacol. 1988;  22 183-190
• 23 Kirby GC, O’Neill MJ, Phillipson JD, Warhurst DC. In vitro studies on the mode of action of quassinoids with activity against chloroquine-resistant Plasmodium falciparum.  Biochem Pharmacol. 1989;  38 4367-4374
• 24 Beutler JA, Kang MI, Robert F, Clement JA, Pelletier J, Colburn NH, McKee TC, Goncharova E, McMahon JB, Henrich CJ. Quassinoid inhibition of AP-1 function does not correlate with cytotoxicity or protein synthesis inhibition.  J Nat Prod. 2009;  72 503-506
• 25 Ristow M, Zarse K, Oberbach A, Klöting N, Birringer M, Kiehntopf M, Stumvoll M, Kahn CR, Blüher M. Antioxidants prevent health-promoting effects of physical exercise in humans.  Proc Nat Acad Sci USA. 2009;  106 8665-8670
• 26 Ristow M, Zarse K. How increased oxidative stress promotes longevity and metabolic health: The concept of mitochondrial hormesis (mitohormesis).  Exp Gerontol. 2010;  45 410-418

Correspondence